GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nexgel NXGL · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.65

+1.25%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Nexgel

From its filings with the US Securities and Exchange Commission

SEC filings

Nexgel is based in Langhorne, Pennsylvania and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker NXGL. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $11.4m and a net loss of $3.0m. At that date it held total assets of $10.5m and shareholders' equity of $4.5m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
22 Dec 2021
Employees
10
Website
nexgel.com ↗
Head office
2150 CABOT BLVD WEST,, LANGHORNE, PA, 19047
Incorporated in
DE
Classification
Surgical & Medical Instruments & Apparatus
Filer status
<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Steven GlassmanIndependent Chairman of the Board$67,875
  • Mr. Adam LevyPresident, Chief Executive Officer, Director, since 2019$437,550
  • Mr. Joseph McGuireChief Financial Officer
  • Mr. Steven CiardielloDirector
  • Mr. Scott HenryIndependent Director$67,875
  • Mr. Nachum SteinIndependent Director$67,875
  • Dr. Jerome ZeldisIndependent Director$67,875
  • Mr. Valter PintoInvestor Relations

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • NexGel Inc manufactures aqueous polymer hydrogels for wound care and medical diagnostics in the US market.
  • NexGel Inc's MedaGel brand offers OTC remedies like blister and pain solutions.
  • NexGel Inc's LumaGel Beauty brand provides cosmetic solutions such as wrinkle and skin creams.

Weaknesses

  • NexGel Inc has only 10 employees which limits its operational capacity.
  • NexGel Inc's manufacturing is based in Langhorne, Pennsylvania, restricting geographic reach.
  • NexGel Inc's IPO on 22 December 2021 is recent, indicating limited market history.

Opportunities

  • NexGel Inc can expand its hydrogel applications into new medical diagnostics markets.
  • NexGel Inc can leverage its proprietary technologies for transdermal drug delivery growth.
  • NexGel Inc can increase international sales of MedaGel and LumaGel Beauty products.

Threats

  • NexGel Inc faces competition from established medical gel manufacturers in the Health Care sector.
  • NexGel Inc's small employee count of 10 may hinder its ability to scale production.
  • NexGel Inc's recent IPO on 22 December 2021 may lead to market volatility for investors.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.